COMP <GO>
TKNO vs NNNN // RETURN ON INVESTED CAPITAL (ROIC)
Alpha Teknova Inc. (NASDAQ) VS. Anbio Biotechnology (Class A) (NASDAQ) • 15-METRIC TALLY: TKNO 2
— NNNN 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: NNNN
LAST: $8.09 (+2.93%) • MKT CAP: $499.2M
roic
-21.30%
LAST: $3.72 (-3.12%) • MKT CAP: $535.3M
roic
17.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. NNNN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TKNO | NNNN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 33.20% | 87.20% | -54.00 | NNNN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -21.30% | 17.00% | -38.30 | NNNN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 91.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.96% | -1.26% | -0.70 | NNNN | /fcf-yield <GO> |
| Operating Margin | -41.90% | 66.70% | -108.60 | NNNN | /operating-margins <GO> |
| Net Profit Margin | -42.60% | 68.00% | -110.60 | NNNN | /net-margins <GO> |
| Revenue Growth (YoY) | 7.40% | 5.60% | +1.80 | TKNO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.93 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 29.4 | +18.67 | TKNO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 77.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $499.2M | $535.3M | -$36.1M | NNNN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TKNO REV | NNNN REV | TKNO GROSS % | NNNN GROSS % | TKNO FCF | NNNN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $40.5M | $8.6M | 33.2% | 87.2% | -$9.8M | -$6.7M |
| FY 2024 | $37.7M | $8.2M | 19.2% | 71.9% | -$13.5M | $2.1M |
| FY 2023 | $36.7M | $6.7M | — | — | -$18.8M | $898.4K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
NNNN // BETA —